In a recent study presented at the American Academy of Dermatology’s annual meeting, researchers examined the efficacy of various doses of an oral JAK1/JAK2 inhibitor for treating patients with...
In a post-hoc analysis of the ALLEGRO phase 2b/3 trial, researchers evaluated whether scalp, eyebrow, and eyelash hair regrowth would continue over 48 weeks in patients with alopecia areata treated with...
Researchers evaluated the efficacy of Janus kinase inhibitors in adult patients with alopecia areata. Their research was presented at the American Academy of Dermatology’s 2023 annual meeting in New...
A recent study that was awarded an honorable mention at the 2018 AAD Annual Meeting identified numerous healthcare and demographic disparities in hospital readmissions for skin disease. We spoke with lead...
The Dermatologist spoke with Joel M. Gelfand, MD, MSCE, professor of dermatology and epidemiology, Perelman School of Medicine, University of Pennsylvania
